Vitamin D role in arterial hypertension development
https://doi.org/10.15829/1728-8800-2012-3-77-81
Abstract
Recently obtained data have identified potential mechanisms linking D-endocrine system and blood pressure regulation. Vitamin D deficiency is associated with calcium metabolism disregulation, increased tonus of renin-angiotensin-aldosterone system, endothelial dysfunction, and metabolic syndrome development. The evidence presented suggests a possibility for developing a new, vitamin D-derived class of antihypertensive medications. This review discusses the mechanisms of arterial hypertension development which are related to vitamin D metabolism in humans.
About the Authors
E. N. Dudinskaya
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
O. N. Tkacheva
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
References
1. Bollerslev J., Rosen T., Mollerup C.L., et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clinl Endocrin & Metab 2009; 94(7): 2255-61.
2. Calvo M.S., Whiting S.J., Barton C.N. Vitamin D intake: a global perspective of current status. J Nutrit 2005; 135(2): 310-6.
3. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutrit 2004; 80(6): 1689-96.
4. Ekmekci A., Abaci N., Ozbey N.C., et al. Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J Endocrinol Invest 2009; 32: 611-6.
5. Fiscella K., Franks P. Vitamin d, race, and cardiovascular mortality. Ann fam med 2010; 8(1): 11-8.
6. Forman J.P., Giovannucci E., Holmes M. D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49(5): 1063-9.
7. Garson-Barre M. The vitamin D 25-Hydroxylase/ Garson-Barre M.// Vitamin D/ eds. Feldman D. San Diego: Academic press 1997; 41-56.
8. Gennari C., Nami R., Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Min and Electrol Metab 1995; 21(1–3): 77-81.
9. Grey A., Lucas J., Horne A., et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrin & Metab 2005; 90(4): 2122-6.
10. Grubbs E.G., Rafeeq S., Jimenez C., et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 2008; 144(6): 852-9.
11. Gupta R.P. CYP3A4 is a human microsomal vitamin D 25-Hydroxylase. J Bone Mineral Research 2004; 19: 680-8.
12. Heaney Robert P., Weaver Connie M. Calcium and vitamin D. Endocrinol Metab Clin N Am 2003; 32: 181-94.
13. Kong J., Qiao G., Zhang Z., et al. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney International 2008; 74(12): 1577-81.
14. Krause R., Buhring M., Hopfenmuller W., et al. Ultraviolet B and blood pressure. The Lancet 1998; 352(9129): 709-10.
15. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig 2002; 110(2): 229-38.
16. Li Y.C., Qiao G., Uskokovic M., et al. VitaminD: a negative endocrine regulator of the reninangiotensin system and blood pressure. J Ster Biochem Molec Biol 2004; 89-90: 387-92.
17. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serumlevels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Inter Med 2007; 167(11): 1159-65.
18. McCarron D.A., Pingree P.A., Rubin R.J., et al. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinarycalcium leak. Hypertension 1980; 2(2): 162-8.
19. Pfeifer M., Begerow B., Minne H. W., et al. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrin& Metab 2001; 86(4): 1633-7.
20. Puepet F.H., Agaba E.I., Chuhwak E.K., et al. Primary hyperparathyroidism presenting with severe hypertension in a middle aged Nigerian—a case report. Nig Postgrad Med J 2008; 15(1): 58-60.
21. Resnick L.M. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 1991; 14(6): 505-20.
22. Resnick L.M., Gupta R.K., Bhargava K.K., et al. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension 1991; 17(6), part 2: 951-7.
23. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30(2): 150-6.
24. Rydberg E., Birgander M., Bondeson A.-G. Effect of successful parathyroidectomy on 24-hour ambulatory blood pressure in patients with primary hyperparathyroidism. Intern J Cardiol 2010; 142(1): 15-21.
25. Sambrook P.N., Chen C.J.S., March L., et al. High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Mineral Res 2006; 21(4): 549-55.
26. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27(12): 2813-8.
27. Silverberg S. Vitamin D deficiency and primary hyperparathyroidism. J Bone Min Res 2007; 22(Supplement 2): V100-4.
28. Sugden J.A., Davies J.I., Witham M.D., et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabetic Med 2008; 25(3): 320-5.
29. Ullah M., Uwaifo G.I., Nicholas W.C., et al. Does Vitamin D Deficiency Cause Hypertension? Current Evidence from Clinical Studies and Potential Mechanisms. International Journal of Endocrinology, Volume 2010, Article ID 579640.
30. Verhave G., Siegert C.E.H. Role of vitamin D in cardiovascular disease. The Nederland J Med 2010; 68(3): 113-8.
31. Watson K.E., Abrolat M.L., Malone L.L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96(6): 1755-60.
32. Zemel M.B., Zemel P.C., Bryg R.J., et al. Dietary calcium induces regression of left ventricular hypertrophy in hypertensive non—insulin-dependent diabetic blacks. Am J Hyperten 1990; 3(6): 458-63.
Review
For citations:
Dudinskaya E.N., Tkacheva O.N. Vitamin D role in arterial hypertension development. Cardiovascular Therapy and Prevention. 2012;11(3):77-81. (In Russ.) https://doi.org/10.15829/1728-8800-2012-3-77-81
Views:
14632
Email this article 
